Quantcast

Neurodegenerative disease: MRI biomarkers — a precision medicine tool in neurology'

Research paper by Corey T. McMillan

Indexed on: 05 Jun '16Published on: 15 Apr '16Published in: Nature Reviews Neurology



Abstract

Two new studies highlight the potential of neuroimaging to aid the differential diagnosis of neurodegenerative disease, for both clinical practice and emerging trials. Although this approach holds great promise, meaningful implementation of neuroimaging as part of a tailored precision medicine strategy may require additional imaging and non-imaging biomarkers.